Background and aims: E1B -deleted virus dl1520 ( ONYX -015 ) has been previously used in clinical trials mainly for treatment of head and neck tumors, and has been shown to have beneficial effects independent of p53 status. The main aim of this investigation was to carry out a preclinical study for assessment of the use of dl1520 in in vitro and in vivo hepatocellular carcinoma ( HCC ) models with various p53 status ( deleted, mutant, and wild type ), and study the ultrastructural changes in the carcinoma cells during and following treatment with dl1520. Methods: dl1520 ( ONYX -015 ) virus was used for treatment of three HCC cell lines in culture, then for treatment of developed xenografts in SCID mice. The effects of dl1520 on HCC cell growth and accompanied morphological changes were assessed by various techniques including transmission electron microscopy. dl1520 infection was confirmed using polymerase chain reaction and immunolabeling at transmission electron microscopy level. Results: dl1520 was effective in killing cells and inhibiting HCC cell growth both in vitro and in vivo. The cell killing was at higher levels in cells possessing abnormal p53. Survival rates in SCID mice treated with dl1520 were statistically significantly higher in HCC tumors with deleted and mutant p53, than in tumors with wild -type p53. Conclusions: The findings in this study suggest that dl1520 could be safely and effectively used for treatment of HCC dependent on the p53 status of the cells in vivo. Characteristic morphological changes that took place in the dl1520 -treated HCC cells / tumors were distinct at transmission electron microscopy level and are the first of their kind to be reported.
L iver tumors are among the most common malignancies, especially hepatocellular carcinoma ( HCC ). 1 The prognosis is poor, with few patients surviving more than 1 year. The only curative options are liver resection or transplantation, 2, 3 and surgical resection can achieve an up to 50% 5-year survival rate 4 where it is attempted. Other options such as radiotherapy, immunotherapy, or chemotherapy have been rarely beneficial; therefore, novel techniques such as gene therapy could provide the best new approach.
In this study, the virus dl1520 that was originally produced by Barker and Berk, 5 but which was renamed ''ONYX -015'', 6 is a replication -deficient adenovirus (Ad ) constructed as a hybrid of Ad type 2 and type 5, with a genome deletion in the E1B region -that is, it does not express the viral 55 -kDa protein, which has been shown to bind to mammalian (tumor suppressor ) p53 7 that induces growth arrest and /or apoptosis through various pathways. 8 Recent studies showed that dl1520 appears to replicate independently of p53 status in many tumor cell lines. 8 -12 dl1520 replication and cytopathic effects, however, are relatively attenuated when compared to wild -type adenovirus replication in a variety of normal cells, including microvascular endothelial cells and epithelial cells. 13 Ganly and colleagues carried out a phase I clinical trial in which they injected dl1520 intratumorally in 22 patients with recurrent head and neck cancer with p53 mutations, and the treatment resulted in substantial necrosis in a significant number of tumors, without apparent damage to normal tissues. 14 Further in vivo experiments and clinical studies showed that dl1520 was effective when administered intratumorally, intra -arterially, and intravenously. 10, 12, 15 Two clinical trials in patients with liver cancers who were treated with dl1520 have been recently published. 16, 17 These studies have confirmed that dl1520 was well tolerated at doses resulting in infection, replication, and chemotherapyassociated antitumoral activity when given as either monotherapy or in combination with chemotherapy. Furthermore ultrastructural examination of tissue showed the presence of adenovirus in cell cytoplasm around the nucleus and revealed two dissimilar endpoints of cell death after virus infection: a preapoptotic sequence and necrosis. However, there are still many questions to be answered including how adenoviral replication kills cells, 18 what are the morphological changes and stages of tumor cell infection and cell death, and what are the bases for growth differences of dl1520 in different cell types. 11, 12, 19 The aims of this study were to assess growth inhibition and morphological changes in HCC cell lines after both dl1520 infection in vitro and direct injection into HCC tumor xenografts in SCID mice.
Methods

Reduced survival of HCC cell lines after infection with dl1520 in vitro
The following human HCC cell lines used were purchased from the European Cell Culture Collection, Salisbury, UK and included HepG2 (wild -type p53 ), Hep3B (p53 -deleted) and PLC /PRF /5 (mutant p53 -codon 249 ). The cells were grown and maintained in Dulbecco's modified Eagle's medium ( DMEM, Gibco BRL, Life Technologies, Paisley, Scotland) supplemented with 10% fetal bovine serum, 2 mM L -glutamine, penicillin ( 50 IU / mL ) and streptomycin ( 50 g/ mL ), at 378C in a humidified incubator (5% CO 2 ). Cultures were split in ratios of 1:3 or 1:4.
Adenoviruses
The adenoviruses used were dl1520 ( donated by Professor A Berk, University of Southern California, Los Angeles, CA ) and Ad -gal (donated by Dr P Seth, National Institutes of Health, Bethesda, MD ). dl1520 has an 827 base -pair deletion in the region encoding the E1B 55-kDa protein, which in combination with a stop codon ensures that a truncated 55 -kDa product cannot be expressed. Ad -gal expresses lacZ and was used for control infections. A 0.9% saline solution was used as a negative control.
Infection of cell cultures
Cell survival studies were performed using each of the three HCC cell lines. For each cell line, experiments were performed using seven replicas ( n= 7 ). Expanding cell cultures were split in a 1:4 ratio and seeded at a density of approximately 2.5Â10 5 cells /mL in T25 culture flasks. The cells were then allowed to grow for 48 hours before infection with 1Â10 8 particles of recombinant adenovirus per T25 flask ( 50 particles /cell ). Briefly, growth media were discarded; cell monolayers were overlaid by recombinant adenovirus suspended in 1 mL of fresh medium and were allowed to stand at room temperature with gentle agitation. After 30 minutes, 15 mL of fresh medium was added and the flasks were reincubated at 378C and 5% CO 2 . Following infection, flasks were removed from the incubator at days 1, 3, and 5 post treatment and cells were trypsinized and counted. The number of viable cells per category was estimated using trypan blue exclusion technique and a hemacytometer. The relative cell survival was estimated by dividing the number of viable cells in the treatment category ( Ad -gal or dl1520 ) by that of the control cultures. The obtained data were statistically analyzed using Kruskal -Wallis and Mann -Whitney tests. Following centrifugation, samples of cells and supernatant were split and stored at À 808C for further analysis.
Direct injection of dl1520 into HCC cell -derived tumor xenografts in SCID mice Inhibition of tumor growth after dl1520 treatment was examined in HepG2 -, Hep3B -, and PLC / PRF /5 -derived xenografts grown in SCID mice. FOX CHASE SCID 2 male mice obtained from M&B ( Ry, Denmark ) were used. Experiments were performed under laminar flow conditions in a defined pathogen -free environment. The SCID mice had health status according to the FELASA recommendations and experiments were reviewed and approved by the institutional committees for both animal care and use, and for recombinant research. Twelve SCID mice were used as tumor hosts, four mice having been injected with the same cell line in each case. Each mouse was allowed to develop three tumors of the given cell line after three subcutaneous injections with approximately 2.5Â10 6 cells suspended in 0.1 mL of Hank's balanced salts solution ( HBSS ). Tumors at the start of the study were between 3 and 5 mm diameter and were allowed to grow for 3 weeks until they became palpable. Tumor diameters were measured twice a week for the 4-week experimental period in two dimensions using a digital vernier scale. During the 4 -week period some mice died prematurely or were sacrificed due to excessive tumor burden. The remaining mice were then killed at the end of 4 weeks.
Tumor treatment with dl1520 adenovirus
There were three treatment categories: ( a) tumors treated with dl1520; ( b) tumors treated with Ad -gal adenovirus; and ( c) tumors treated with saline solution only. Respectively, tumors were injected with 1Â10 8 particles of dl1520 or Ad -gal adenovirus diluted in 0.1 mL of 0.9% saline solution, whereas negative control tumors were injected with 0.9% saline solution; treatments were given over three consecutive days when the tumors reached 5 mm in diameter.
Collection and analysis of tumor tissues
Tumors were prepared from every mouse; one tumor was snap -frozen in liquid nitrogen, one was fixed in 4% paraformaldehyde, and one was embedded in Tissue-Tek OCT-compound (Sakura Finetek, Zoeterwoude, The Netherlands ). From each group, organs, blood, and snap -frozen tumors were stored at À 808C for further analysis, and samples of the paraformaldehyde -fixed tissues were stained for -galactosidase activity and electron microscopy. DNA from treated and control tumors was extracted using the standard phenol / chloroform technique. 20 Samples of extracted DNA were analyzed for presence of adenovirus type 5 (Ad5 ) DNA sequence, using polymerase chain reaction ( PCR ), in the presence of a pair of primers designed to amplify a 590 -bp fragment of the Ad5 backbone of dl1520 virus. 21 Samples of the PCR products were analyzed using 1% agarose gel electrophoresis.
Results
Reduced survival of HCC cell lines after infection with dl1520 in vitro
Comparison of mean relative cell survival in the three HCC cell line models showed that by day 4 (day 5 for PLC /PRF / 5 cells ) there was a statistically significant difference in cell survival (Fig 1) between the dl1520 -treated cells and both the Ad -gal and saline controls, which was independent of p53 status. This was confirmed when both the KruskalWallis and Mann -Whitney tests (Table 1 ) were applied to the model. Figure 2 shows changes in the mean relative tumor size of treated tumors at various time points compared to pretreatment tumor size in the three SCID mouse models ( HepG2 -, Hep3B -, and PLC /PRF / 5-derived tumors ). The rates of increase in tumor size in mice showed that dl1520 was effective in growth inhibition in the Hep3B (deleted p53) and PLC / PRF /5 (mutant p53) groups compared to controls. However, inhibition of HepG2 ( wild -type p53 ) tumors did not reach statistical significance. Table 2 summarizes the P value analysis results obtained using a random effect regression model. Survival results obtained using log rank tests showed highly significant overall differences between the three treatment groups for Hep3B -and PLC /PRF /5 -derived tumors ( Fig 2) . Median time before animal death indicated that survival in the dl1520 -treated mice was longer than that of the other two treatment groups (1.4-to 3.4 -fold ). In HepG2-derived groups, there was no significant difference between saline-and dl1520 -treated groups ( Table 2) .
Direct injection of dl1520 into HCC cell -derived tumor xenografts in SCID mice
Morphological changes in the cell cultures and in HCC tumor xenografts in SCID mice following direct intratumoral injection of dl1520
When these HCC cells were grown in SCID mice, they developed into tumors whose cellular morphology strongly resembled that of original HepG2, Hep3B and PLC /PRF /5 cell cultures, and indeed of hepatocytes. At electron microscope level, although pleomorphic, tumor cells of 30 -80 m in diameter were seen closely apposed to each other, frequently with bile canaliculus -like differentiation on their lateral plasma membranes. In tissue sections, the majority of cells were uninuclear, but binucleate cells were not uncommon, in which case, in control tumors, the two nuclei were identical. Apoptotic cells were present in the tumors, but quantitative assessment was not undertaken due to statistical constraints on morphological observation that cannot be overcome at electron microscope level.
Analysis of cell cultures and HCC tumor xenografts at TEM level after treatment with dl1520
After virus infection, there appeared to be two nonresembling endpoints of cell death, a preapoptotic sequence and necrosis. In the first the series of events observed was: uptake of viruses into cells ( Fig 3 ) and their translocation across the cytoplasm to perinuclear locations, followed by nuclear membrane deterioration (thus permitting access of viral DNA to nuclear DNA ). Nuclei then shrunk leaving viruses / viral debris /nuclear membrane debris at the nuclear perimeters ( Fig 4 ) , and the following morphological changes typical of apoptosis -chromatin condensation, cytoplasmic condensation and ultimately phagocytosis and degradation of apoptotic bodies (Figs 5 and 6) were seen. While undergoing the early stages of the process organelles retained normal morphology, appearing to remain functionalanother typical apoptotic characteristic. Observation of the sequence was not derived from sampling tumors at different time points. The processes did not occur in all cells simultaneously across the samples; progressive stages were seen in neighboring cells at the same instant. Viruses could be seen associated with apoptotic cells, but due to cytoplasmic condensation, viruses were only visible when they were within electron lucent vacuoles. These morphological changes closely resembled those seen after viral infection of the same cell types in vitro.
The second variety of cell death was significant cell lysis seen in some areas of tumors. These zones appeared nonviable, with cells demonstrating typical criteria associated with necrosis -cell swelling, breaches of the plasma membrane, total rupture and swelling of the nucleus, lysis of all organelles. Here, viruses were present in superabundant numbers ( Fig 7) compared to cells in the preapoptotic sequence, filling the whole of the cytoplasm and causing haphazard destruction of nucleus and cytoplasm.
The general pattern of morphological cell changes and cell damage after viral infection ended in the same divergent formats of cell death, one set of events ending in apoptosis, the other in necrosis. In both in vitro and in vivo experiments considering the procedures in the preapoptotic sequence, when cells were binucleate and one nucleus had a greater level of infection than its neighbor, this nucleus had a Cell lines of three different HCC tumor types were treated either with dl1520 ( n = 7 each ), saline ( n = 7 ) or Ad -gal ( n = 7 for each of HepG2 and Hep3B ). Mann -Whitney tests were used to compare the dl1520 -treated cell lines with Ad -gal -and saline -treated cell lines, and the P values obtained were as shown in the table. characteristic sheath of viruses and products of viral deterioration around the nuclear membrane; such nuclei were shrunken and damaged. In areas of necrosis also, the pathological changes were typical, and clearly the result of the presence of superabundant intracellular viruses.
Discussion
The results from the experiments in which HCC cell lines were infected with dl1520 in vitro showed that the virus was effective in killing the three HCC cell lines independent of the p53 status consistent with previously published work by other groups. 8 -10,22 Cells of the HepG2 and Hep3B cultures were all dead by day 4 and all cells of PLC /PRF /5 cultures were dead by day 5. Results from the studies of direct injection of dl1520 into xenografts derived from the above cell lines grown in SCID mice, showed that the virus inhibited growth of Hep3B and PLC / PRF /5 tumors; this was also associated with survival of all the treated animals to the designated killing point, in contrast to some of the nonvirus treated controls. However, inhibition of HepG2 tumor growth and host survival time post dl1520 treatment were Table 2 Effects of direct injection of dl1520 into HCC cell -derived tumor xenografts in SCID mice in in vivo experiments A. P values resulting from analyses of the rate of tumor volume increase in the SCID mice dl1520 vs saline ratio dl1520 vs -gal ratio Changes in tumor size over time were compared across the three infected groups for each cell line and data were analyzed using a random effects regression model. *Values are presented as median survival time in days ( corresponding interquartile range ).
HepG2 ( normal p53
Analyses of the length of survival of each mouse in the study before being killed ( see Methods ). As each mouse can only be killed once, but had three tumors, there is only one measurement per mouse, rather than one measurement per tumor. The comparisons between dl1520 -and saline -or Ad -gal -treated animals were assessed by the use of log rank tests.
P values resulting from these analyses are in the table. Electron micrograph of the nucleus of a cultured Hep3B cell after infection with dl1520. Cytoplasm contains many viral particles, V, particularly in the vicinity of the nuclear membrane. Nuclear shape is distorted due to shrinkage, and normal double nuclear membrane is replaced by a zone of fine electron dense debris ( arrows ) that appears to consist of elements of deteriorating membrane, degraded viruses, and viral capsids. Bar = 2.5 m.
Cancer Gene Therapy
Effects of dl 1520 on hepatocellular carcinoma cells and tumours NA Habib et al not significant compared to the saline treated group. This study has shown that dl1520 has been effective in killing cancer cells in deleted and abnormal type p53 but not in wild -type p53 implying the effect of dl1520 is dependent of p53 status in vivo.
Morphological changes in tumor cells in the mice were identical to those seen in the treated HCC cell cultures. Viruses were found in cell cytoplasm, sheathing nuclei, and associated with cell shrinkage and progression toward apoptosis. Alternatively, typically bordering widespread areas of tumor necrosis, cells bursting due to the effects of superabundant viruses were prominent. In both cases, the result of viral infection was cell death, either by apoptosis or necrosis.
The differences in cell death by these heterogeneous mechanisms have been defined and recognized for a number of years. 23 Ultrastructure of morphological changes during formation of apoptotic bodies recognized stages including reduction in volume of the nucleus, chromatin condensation, and cytoplasmic compression, though considerable maintenance of organelle integrity remained, 24 all of which could be found in all samples, in vitro and in vivo, studied in this investigation. In normal circumstances, these events are controlled by cascades of specific families of molecules, controlled by activation of the cells' genes. In this study, when therapeutic adenoviruses entered target cells, they were able to cross the cytosol and destroy nuclear membranes allowing access for their genome to enter the target cell nucleus, clearly influencing outcome in the genetic control of apoptosis. The disassembly of viral coat components is stepwise 25 and here we have consistently witnessed viruses / viral capsid remnants halted at deteriorating nuclear membranes.
Where cells contained superabundant numbers of virus, the result was membrane and organelle destruction and widespread necrosis. Whether the complement of viruses seen in these cells was a result of viral replication or of uneven uptake of viral dose, however, has not been determined. Figure 5 Low -power electron micrograph of two adjacent cells from a Hep3B cell -derived tumor grown in an SCID mouse after infection with dl1520. The nucleus of cell H is surrounded by a sheath of viral particles ( small arrows ), but otherwise the cell is intact. Cell A, however, is undergoing apoptosis and is already split into five discernible apoptotic bodies; two of these have been phagocytosed by cell H ( large arrows ), whereas the largest fragment contains the cell nucleus, N, with typically condensed chromatin. Bar = 5.7 m. Electron micrograph of a cell from a Hep3B cell -derived tumor grown in an SCID mouse, after infection with dl1520. The cell is replete with a superabundance of viruses ( arrows ). Intact organelles cannot be identified, nuclear membrane no longer exists, and the plasma membrane has multiple breaches and distortions. Neighboring cells also, N, are typically necrotic, represented by cytoplasmic debris. Bar = 3.75 m.
In conclusion, the results of this study shed light on the morphological changes occurring in the HCC -derived cells following infection. Also, the results showed that dl1520 virus was safe and effective in killing the tumor cells in vitro and in xenografts in vivo, and has improved survival in the SCID mouse HCC models with deleted and abnormal p53 when compared to controls. Indeed, this study formed the basis of a phase I clinical trial in the use of dl1520 in the treatment of human HCC tumors.
